Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms KTX 115 |
Target |
Mechanism STAT3 modulators(Signal transducer and activator of transcription 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cutaneous T-Cell Lymphoma | Preclinical | US | 12 Dec 2022 | |
Cutaneous T-Cell Lymphoma | Preclinical | US | 12 Dec 2022 |